Observational Study in Localized Osteosarcoma
Sponsored by Italian Sarcoma Group
About this trial
Last updated 2 years ago
Study ID
AIEOP/ISGOS2 Oss
Status
Recruiting
Type
Observational
Placebo
No
Accepting
Up to 40 Years
All
Not accepting
Healthy Volunteers
Trial Timing
Started 4 years ago
What is this trial about?
Observational prospective trial aimed to collect the collect demographic, clinical, surgical,
pathological and molecular characteristics and treatment from patients affected by localized
OsteoSarcoma (OS) treated according the AIEOP/Italian Sarcoma Group (ISG) OS 2021
What are the participation requirements?
Inclusion Criteria
- Diagnosis of high grade OS of the extremities
- Age at diagnosis ≤ 40 years at the time of diagnosis
- Localized disease (skip metastases are allowed)
- Adequate organ function according the AIEOP/ISG OS 2021 recommendation
- Patients or parents oe guardians of minors who have given their written informed consent to participate in the study
Exclusion Criteria
- Presence of metastases
- Diagnosis of periosteal OS, of parosteal OS or secondary OS
- Any medical condition which can not allowed the use of the treatments recommended by AIEOP/ISG OS 2021
Locations
Location
Status
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Not yet recruiting
Not yet recruiting